|
⚲
|
| Keyboard |
| venBio Global Strategic GP LP | |
|---|---|
| Firm | Avoro Capital Advisors LLC |
| Address | c/o venBio Partners LLC 1700 Owens Street, Suite 595 San Francisco, CA 94158 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | |||||
| venBio Global Strategic Fund LP | 021-150376 | Director | 177.0 M of 237.0 M |
178.8 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Metacrine Inc MTCR
Common Stock
|
2021-10-25 | Sell | 540,667 | $1.49 | 805,594 |
|
Metacrine Inc MTCR
Common Stock
|
2021-10-22 | Sell | 75,035 | $1.64 | 123,057 |
|
Metacrine Inc MTCR
Common Stock
|
2020-09-18 | Buy | 230,000 | $13.00 | 2,990,000 |
|
Metacrine Inc MTCR
Common Stock
|
2020-09-18 | Conversion | 2,829,123 | ||
|
Metacrine Inc MTCR
Series A Convertible Preferred Stock · derivative
|
2020-09-18 | Conversion | 1,960,784 | $0.00 | |
|
Metacrine Inc MTCR
Series C Convertible Preferred Stock · derivative
|
2020-09-18 | Conversion | 396,089 | $0.00 | |
|
Metacrine Inc MTCR
Series B Convertible Preferred Stock · derivative
|
2020-09-18 | Conversion | 472,250 | $0.00 | |
|
ALX Oncology Holdings Inc ALXO
Series B Convertible Preferred Stock · derivative
|
2020-07-21 | Conversion | 490,411 | ||
|
ALX Oncology Holdings Inc ALXO
Series A Convertible Preferred Stock · derivative
|
2020-07-21 | Conversion | 3,100,020 | ||
|
ALX Oncology Holdings Inc ALXO
Series A Convertible Preferred Stock · derivative
|
2020-07-21 | Conversion | 2,398,588 | ||
|
ALX Oncology Holdings Inc ALXO
Common Stock
|
2020-07-21 | Conversion | 3,100,020 | ||
|
ALX Oncology Holdings Inc ALXO
Common Stock
|
2020-07-21 | Conversion | 3,941,949 | ||
|
ALX Oncology Holdings Inc ALXO
Common Stock
|
2020-07-21 | Conversion | 78,175 | ||
|
ALX Oncology Holdings Inc ALXO
Common Stock
|
2020-07-21 | Buy | 850,000 | $19.00 | 16,150,000 |
|
ALX Oncology Holdings Inc ALXO
Common Stock
|
2020-07-21 | Buy | 3,000 | $19.00 | 57,000 |
|
ALX Oncology Holdings Inc ALXO
Series A Convertible Preferred Stock · derivative
|
2020-07-21 | Conversion | 78,175 | ||
|
ALX Oncology Holdings Inc ALXO
Series C Convertible Preferred Stock · derivative
|
2020-07-16 | Conversion | 1,052,950 | ||
|
Precision Biosciences Inc DTIL
Series A Preferred Stock · derivative
|
2019-04-01 | Conversion | 8,000,000 | $0.00 | |
|
Precision Biosciences Inc DTIL
Common Stock
|
2019-04-01 | Conversion | 3,747,623 | ||
|
Precision Biosciences Inc DTIL
Series B Preferred Stock · derivative
|
2019-04-01 | Conversion | 998,004 | $0.00 | |
| showing 20 of 22 most recent transactions | |||||